Press Releases
June 22, 2021
Washington, D.C. (June 22, 2021) — Today, the Select Subcommittee on the Coronavirus Crisis, chaired by Rep. James E. Clyburn, held a hearing with Federal Reserve (Fed) Chair Jerome H.
June 22, 2021
Washington, D.C. (June 22, 2021) — Today, Rep. James E. Clyburn, Chairman of the Select Subcommittee on the Coronavirus Crisis, delivered the following opening statement at today's hybrid hearing with Federal Reserve (Fed) Chair Jerome H. Powell:
June 17, 2021
Washington, D.C. (June 17, 2021) — Today, Rep. James E.
June 16, 2021
Washington, D.C. (June 16, 2021) —On Tuesday, June 22, 2021 at 2:00 p.m., Rep. James E. Clyburn, Chairman of the Select Subcommittee on the Coronavirus Crisis, will hold a hybrid remote / in-person hearing with Federal Reserve (Fed) Chairman Jerome H. Powell.
June 11, 2021
Washington, D.C. (June 11, 2021)—Today, Rep. James E. Clyburn, Chairman of the Select Subcommittee on the Coronavirus Crisis, and Rep. Carolyn B. Maloney, Chairwoman of the Committee on Oversight and Reform, issued the following statement after the Food and Drug Administration (FDA) announced that numerous batches—reportedly totaling 60 million doses—of the Johnson & Johnson coronavirus vaccine manufactured by Emergent BioSolutions, Inc. (Emergent) "are not suitable for use" due to contamination. |
June 3, 2021
Washington, D.C. (June 3, 2021) —Today, Rep. James E. Clyburn, Chairman of the Select Subcommittee on the Coronavirus Crisis, launched an investigation into a $700 million loan awarded by the Department of the Treasury (Treasury) with the involvement of the Department of Defense (DOD) under the Trump Administration as part of a program intended to support companies that were critical to maintaining U.S. national security during the coronavirus pandemic. In letters to Treasury Secretary Janet Yellen, Defense Secretary Lloyd J.
May 28, 2021
Washington, D.C. (May 28, 2021) — Yesterday, Rep. James E. Clyburn, Chairman of the Select Subcommittee on the Coronavirus Crisis, sent letters to four financial technology (FinTech) firms and partner banks seeking documents and information related to their handling of Paycheck Protection Program (PPP) loans. The requests follow reports that FinTech companies and bank partners have been linked to a disproportionate number of fraudulent PPP loans.
May 19, 2021
Washington, D.C. (May 19, 2021) – Today, the Select Subcommittee on the Coronavirus Crisis, chaired by Rep. James E. Clyburn, held a hybrid hearing with Emergent BioSolutions, Inc.'s (Emergent) President and Chief Executive Officer, Robert G. Kramer, and Executive Chairman, Fuad El-Hibri.
May 19, 2021
Washington D.C. (May 19, 2021)—Today, Rep. James E. Clyburn, Chairman of the Select Subcommittee on the Coronavirus Crisis, Rep. Frank Pallone, Jr., Chairman of the Committee on Energy and Commerce, Rep. Richard E. Neal, Chairman of the Committee on Ways and Means, and Rep. Carolyn B. Maloney, Chairwoman of the Committee on Oversight and Reform, issued the following statement after the Government Accountability Office (GAO) released a report evaluating the spread of coronavirus in nursing homes across the United States: